Treatment of Ulcers Complicated by Infection
For ulcers complicated by infection, the recommended treatment is a broad-spectrum antibiotic regimen targeting gram-positive, gram-negative, and anaerobic bacteria, initiated as soon as possible after peritoneal fluid collection, with a short course of 3-5 days or until inflammatory markers normalize. 1
Antibiotic Selection
Non-critically Ill Patients
- First-line therapy: Piperacillin/tazobactam 4.5g every 6 hours 1
- Alternative regimens:
Critically Ill Patients
- First-line options:
- For patients at risk of ESBL-producing Enterobacteriaceae:
Special Considerations
- For beta-lactam allergies: Ciprofloxacin 400mg every 8 hours plus metronidazole 500mg every 6 hours 1
- For H. pylori-associated ulcers: Triple therapy with proton pump inhibitor (e.g., omeprazole 20mg twice daily), clarithromycin 500mg twice daily, and amoxicillin 1g twice daily for 14 days 2, 3, 4
Duration of Therapy
- Short-course (3-5 days) antibiotic therapy is recommended for perforated peptic ulcer if adequate source control is achieved 1
- Continue antibiotics until resolution of fever, leukocytosis, and ileus 1
- For H. pylori eradication in ulcer disease, complete the full 14-day course of therapy 2, 3
Antifungal Considerations
- Routine antifungal therapy is not recommended for all patients with perforated peptic ulcer 1
- Reserve antifungal therapy for high-risk patients:
Management Approach
- Collect peritoneal fluid samples before initiating antibiotics when possible 1
- Adjust antibiotic therapy based on culture results and clinical response 1
- For perforated ulcers, surgical intervention with adequate source control is essential alongside antibiotic therapy 1
- For bleeding ulcers, early endoscopy (within 24 hours) is recommended for both therapeutic intervention and prognostic assessment 1
Common Pitfalls to Avoid
- Delaying antibiotic administration after diagnosis can increase morbidity and mortality 5
- Unnecessarily prolonged antibiotic courses do not improve outcomes but increase the risk of antimicrobial resistance 1
- Inadequate anaerobic coverage can lead to treatment failure in intra-abdominal infections 1
- Failure to adjust empiric therapy based on culture results and clinical response 1
- Overlooking the need for H. pylori eradication in patients with peptic ulcer disease, which reduces recurrence rates from 50-60% to 0-2% 4